Diabetic Retinopathy Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Diabetic Retinopathy Treatment Market: Drug Type (Aflibercept, Ranibizumab, Corticosteroids, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel (HOSPITAL PHARMACIES, RETAIL PHARMACIES, ONLINE PHARMACIES), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Diabetic Retinopathy Treatment Market Introduction
2.1. Global Diabetic Retinopathy Treatment Market – Taxonomy
2.2. Global Diabetic Retinopathy Treatment Market –Definitions
2.2.1. Drug Type
2.2.2. Route of Administration
2.2.3. Distribution Channel
3. Global Diabetic Retinopathy Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Diabetic Retinopathy Treatment Market Dynamic Factors – Impact Analysis
3.6. Global Diabetic Retinopathy Treatment Market – Competition Landscape
4. Global Diabetic Retinopathy Treatment Market, By Drug Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1. Aflibercept
4.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Ranibizumab
4.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Corticosteroids
4.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
4.4. Others
4.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.4.3. Market Opportunity Analysis
5. Global Diabetic Retinopathy Treatment Market Forecast, By Route of Administration, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
5.1. Oral
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Parenteral
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Diabetic Retinopathy Treatment Market, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. HOSPITAL PHARMACIES
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. RETAIL PHARMACIES
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. ONLINE PHARMACIES
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Diabetic Retinopathy Treatment Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By Drug Type, Route of Administration, Distribution Channel and Region, 2022-2028
8. North America Diabetic Retinopathy Treatment MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Aflibercept
8.1.2. Ranibizumab
8.1.3. Corticosteroids
8.1.4. Others
8.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Oral
8.2.2. Parenteral
8.2.3. Others
8.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.3.1. HOSPITAL PHARMACIES
8.3.2. RETAIL PHARMACIES
8.3.3. ONLINE PHARMACIES
8.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.4.1. USA
8.4.2. Canada
8.5. North America Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
8.6. North America Diabetic Retinopathy Treatment Market Dynamics – Trends
9. Europe Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Aflibercept
9.1.2. Ranibizumab
9.1.3. Corticosteroids
9.1.4. Others
9.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Oral
9.2.2. Parenteral
9.2.3. Others
9.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. HOSPITAL PHARMACIES
9.3.2. RETAIL PHARMACIES
9.3.3. ONLINE PHARMACIES
9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. Germany
9.4.2. UK
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Poland
9.4.8. Rest of Europe
9.5. Europe Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By  Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
9.6. Europe Diabetic Retinopathy Treatment Market Dynamics – Trends
10. Asia-Pacific Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Aflibercept
10.1.2. Ranibizumab
10.1.3. Corticosteroids
10.1.4. Others
10.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Oral
10.2.2. Parenteral
10.2.3. Others
10.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. HOSPITAL PHARMACIES
10.3.2. RETAIL PHARMACIES
10.3.3. ONLINE PHARMACIES
10.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. ASEAN
10.4.5. Australia & New Zealand
10.4.6. Rest of Asia-Pacific
10.5. Asia-Pacific Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By  Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
10.6. Asia-Pacific Diabetic Retinopathy Treatment Market Dynamics – Trends
11. Latin America Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Aflibercept
11.1.2. Ranibizumab
11.1.3. Corticosteroids
11.1.4. Others
11.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Oral
11.2.2. Parenteral
11.2.3. Others
11.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. HOSPITAL PHARMACIES
11.3.2. RETAIL PHARMACIES
11.3.3. ONLINE PHARMACIES
11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
11.5. Latin America Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
11.6. Latin America Diabetic Retinopathy Treatment Market Dynamics – Trends
12. Middle East and Africa Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Aflibercept
12.1.2. Ranibizumab
12.1.3. Corticosteroids
12.1.4. Others
12.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Oral
12.2.2. Parenteral
12.2.3. Others
12.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. HOSPITAL PHARMACIES
12.3.2. RETAIL PHARMACIES
12.3.3. ONLINE PHARMACIES
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Gulf Cooperation Council (GCC) Countries
12.4.2. Israel
12.4.3. South Africa
12.4.4. Rest of MEA
12.5. MEA Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By  Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
12.6. MEA Diabetic Retinopathy Treatment Market Dynamics – Trends
13. Global Diabetic Retinopathy Treatment – Pipeline Drug Analysis
13.1. Global Diabetic Retinopathy Treatment Disease Epidemiology
13.2 Global Diabetic Retinopathy Treatment, Pipeline Drugs Assessment
13.3. Global Diabetic Retinopathy Treatment, Pipeline Drugs Assessment – Sponsors/Companies
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Route of Administration& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Regeneron Pharmaceuticals
14.2.2. Novartis AG
14.2.3. Genentech
14.2.4. Novartis AG
14.2.5. Bayer AG
14.2.6. Oxurion
14.2.7. OccuRx
14.2.8. AptaBio Therapeutics
14.2.9. Kodiak Sciences
14.2.10. RemeGen
14.2.11. F. Hoffman-La-Roche AG.
14.2.12. Grifols S.A.
15. Research Methodology
16. Key Assumptions and Acronymsc

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

 

  • PCA
  • Obaji
  • PHYTOMER
  • Skin Medica
  • Skin Better Science
  • Colorescience
  • Sente
  • Jan Marini Skin Research
  • Revision Skincare
  • The BeautyHealth Company
  • Glow Biotics LLC
  • Perricone MD
  • Mdalgorithms, Inc.

Description

1. Executive Summary
2. Global Diabetic Retinopathy Treatment Market Introduction
2.1. Global Diabetic Retinopathy Treatment Market – Taxonomy
2.2. Global Diabetic Retinopathy Treatment Market –Definitions
2.2.1. Drug Type
2.2.2. Route of Administration
2.2.3. Distribution Channel
3. Global Diabetic Retinopathy Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Diabetic Retinopathy Treatment Market Dynamic Factors – Impact Analysis
3.6. Global Diabetic Retinopathy Treatment Market – Competition Landscape
4. Global Diabetic Retinopathy Treatment Market, By Drug Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1. Aflibercept
4.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Ranibizumab
4.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Corticosteroids
4.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
4.4. Others
4.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.4.3. Market Opportunity Analysis
5. Global Diabetic Retinopathy Treatment Market Forecast, By Route of Administration, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
5.1. Oral
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Parenteral
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Diabetic Retinopathy Treatment Market, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. HOSPITAL PHARMACIES
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. RETAIL PHARMACIES
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. ONLINE PHARMACIES
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Diabetic Retinopathy Treatment Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By Drug Type, Route of Administration, Distribution Channel and Region, 2022-2028
8. North America Diabetic Retinopathy Treatment MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Aflibercept
8.1.2. Ranibizumab
8.1.3. Corticosteroids
8.1.4. Others
8.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Oral
8.2.2. Parenteral
8.2.3. Others
8.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.3.1. HOSPITAL PHARMACIES
8.3.2. RETAIL PHARMACIES
8.3.3. ONLINE PHARMACIES
8.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.4.1. USA
8.4.2. Canada
8.5. North America Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
8.6. North America Diabetic Retinopathy Treatment Market Dynamics – Trends
9. Europe Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Aflibercept
9.1.2. Ranibizumab
9.1.3. Corticosteroids
9.1.4. Others
9.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Oral
9.2.2. Parenteral
9.2.3. Others
9.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. HOSPITAL PHARMACIES
9.3.2. RETAIL PHARMACIES
9.3.3. ONLINE PHARMACIES
9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. Germany
9.4.2. UK
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Poland
9.4.8. Rest of Europe
9.5. Europe Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By  Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
9.6. Europe Diabetic Retinopathy Treatment Market Dynamics – Trends
10. Asia-Pacific Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Aflibercept
10.1.2. Ranibizumab
10.1.3. Corticosteroids
10.1.4. Others
10.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Oral
10.2.2. Parenteral
10.2.3. Others
10.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. HOSPITAL PHARMACIES
10.3.2. RETAIL PHARMACIES
10.3.3. ONLINE PHARMACIES
10.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. ASEAN
10.4.5. Australia & New Zealand
10.4.6. Rest of Asia-Pacific
10.5. Asia-Pacific Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By  Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
10.6. Asia-Pacific Diabetic Retinopathy Treatment Market Dynamics – Trends
11. Latin America Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Aflibercept
11.1.2. Ranibizumab
11.1.3. Corticosteroids
11.1.4. Others
11.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Oral
11.2.2. Parenteral
11.2.3. Others
11.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. HOSPITAL PHARMACIES
11.3.2. RETAIL PHARMACIES
11.3.3. ONLINE PHARMACIES
11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
11.5. Latin America Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
11.6. Latin America Diabetic Retinopathy Treatment Market Dynamics – Trends
12. Middle East and Africa Diabetic Retinopathy Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Drug Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Aflibercept
12.1.2. Ranibizumab
12.1.3. Corticosteroids
12.1.4. Others
12.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Oral
12.2.2. Parenteral
12.2.3. Others
12.3. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. HOSPITAL PHARMACIES
12.3.2. RETAIL PHARMACIES
12.3.3. ONLINE PHARMACIES
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Gulf Cooperation Council (GCC) Countries
12.4.2. Israel
12.4.3. South Africa
12.4.4. Rest of MEA
12.5. MEA Diabetic Retinopathy Treatment Market – Opportunity Analysis Index, By  Drug Type, Route of Administration, Distribution Channel, and Country, 2022-2028
12.6. MEA Diabetic Retinopathy Treatment Market Dynamics – Trends
13. Global Diabetic Retinopathy Treatment – Pipeline Drug Analysis
13.1. Global Diabetic Retinopathy Treatment Disease Epidemiology
13.2 Global Diabetic Retinopathy Treatment, Pipeline Drugs Assessment
13.3. Global Diabetic Retinopathy Treatment, Pipeline Drugs Assessment – Sponsors/Companies
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Route of Administration& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Regeneron Pharmaceuticals
14.2.2. Novartis AG
14.2.3. Genentech
14.2.4. Novartis AG
14.2.5. Bayer AG
14.2.6. Oxurion
14.2.7. OccuRx
14.2.8. AptaBio Therapeutics
14.2.9. Kodiak Sciences
14.2.10. RemeGen
14.2.11. F. Hoffman-La-Roche AG.
14.2.12. Grifols S.A.
15. Research Methodology
16. Key Assumptions and Acronymsc

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX